{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T10:04:21Z","timestamp":1768557861706,"version":"3.49.0"},"reference-count":31,"publisher":"e-Century Publishing Corporation","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/lude7524","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T03:35:57Z","timestamp":1727667357000},"page":"4353-4366","source":"Crossref","is-referenced-by-count":4,"title":["Uncovering the role of FXYD3 as a potential oncogene and early biomarker in pancreatic cancer"],"prefix":"10.62347","volume":"14","author":[{"given":"Ke Xin","family":"Yee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"882","DOI":"10.3390\/cancers14040882","article-title":"Prediction model for pancreatic cancer-a population-based study from NHIRD","volume":"14","author":"HA","year":"2022","unstructured":"Lee HA, Chen KW and Hsu CY. Prediction model for pancreatic cancer-a population-based study from NHIRD. Cancers (Basel) 2022; 14: 882.","journal-title":"Cancers (Basel)"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE and Jemal A. Cancer statistics, 2021. CA Cancer J Clin 2021; 71: 7-33.","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.3748\/wjg.v27.i27.4298","article-title":"Pancreatic cancer: a review of epidemiology, trend, and risk factors","volume":"27","author":"JX","year":"2021","unstructured":"Hu JX, Zhao CF, Chen WB, Liu QC, Li QW, Lin YY and Gao F. Pancreatic cancer: a review of epidemiology, trend, and risk factors. World J Gastroenterol 2021; 27: 4298-4321.","journal-title":"World J Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","article-title":"Molecular principles of metastasis: a hallmark of cancer revisited","volume":"5","author":"Fares","year":"2020","unstructured":"Fares J, Fares MY, Khachfe HH, Salhab HA and Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther 2020; 5: 28.","journal-title":"Signal Transduct Target Ther"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"5255","DOI":"10.3390\/ijms21155255","article-title":"Distant metastasis in colorectal cancer patients-do we have new predicting clinicopathological and molecular biomarkers? A comprehensive review","volume":"21","author":"Filip","year":"2020","unstructured":"Filip S, Vymetalkova V, Petera J, Vodickova L, Kubecek O, John S, Cecka F, Krupova M, Manethova M, Cervena K and Vodicka P. Distant metastasis in colorectal cancer patients-do we have new predicting clinicopathological and molecular biomarkers? A comprehensive review. Int J Mol Sci 2020; 21: 5255.","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cell.2011.11.025","article-title":"EMT and dissemination precede pancreatic tumor formation","volume":"148","author":"Rhim","year":"2012","unstructured":"Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F, Reichert M, Beatty GL, Rustgi AK, Vonderheide RH, Leach SD and Stanger BZ. EMT and dissemination precede pancreatic tumor formation. Cell 2012; 148: 349-361.","journal-title":"Cell"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Usón PLS Junior, Tolentino FDS, Santos VM, Rother ET and Maluf FC. The impact of metastatic sites in advanced pancreatic adenocarcinoma, systematic review and meta-analysis of prospective randomized studies. PLoS One 2020; 15: e0230060.","DOI":"10.1371\/journal.pone.0230060"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nature16064","article-title":"Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer","volume":"527","author":"Zheng","year":"2015","unstructured":"Zheng X, Carstens JL, Kim J, Scheible M, Kaye J, Sugimoto H, Wu CC, LeBleu VS and Kalluri R. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature 2015; 527: 525-530.","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ijrobp.2023.02.061","article-title":"Carbohydrate Antigen 19-9 response to initial adjuvant chemotherapy predicts survival and failure pattern of resected pancreatic adenocarcinoma but not which patients are suited for additional adjuvant chemoradiation therapy: from a prospective randomized study","volume":"117","author":"YF","year":"2023","unstructured":"Chiu YF, Liu TW, Shan YS, Chen JS, Li CP, Ho CL, Hsieh RK, Hwang TL, Chen LT and Ch’ang HJ; Taiwan Cooperative Oncology Group pancreatic cancer study group. Carbohydrate Antigen 19-9 response to initial adjuvant chemotherapy predicts survival and failure pattern of resected pancreatic adenocarcinoma but not which patients are suited for additional adjuvant chemoradiation therapy: from a prospective randomized study. Int J Radiat Oncol Biol Phys 2023; 117: 74-86.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1080\/1354750X.2020.1725786","article-title":"Elevated CEA and CA19-9 serum levels independently predict advanced pancreatic cancer at diagnosis","volume":"25","author":"van Manen","year":"2020","unstructured":"van Manen L, Groen JV, Putter H, Vahrmeijer AL, Swijnenburg RJ, Bonsing BA and Mieog JSD. Elevated CEA and CA19-9 serum levels independently predict advanced pancreatic cancer at diagnosis. Biomarkers 2020; 25: 186-193.","journal-title":"Biomarkers"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Li JR, Sun CH, Li W, Chao RF, Huang CC, Zhou XJ and Liu CC. Cancer RNA-Seq Nexus: a database of phenotype-specific transcriptome profiling in cancer cells. Nucleic Acids Res 2016; 44: D944-951.","DOI":"10.1093\/nar\/gkv1282"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Zheng G, Ma Y, Zou Y, Yin A, Li W and Dong D. HCMDB: the human cancer metastasis database. Nucleic Acids Res 2018; 46: D950-D955.","DOI":"10.1093\/nar\/gkx1008"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41416-020-01178-9","article-title":"EMTome: a resource for pan-cancer analysis of epithelial-mesenchymal transition genes and signatures","volume":"124","author":"Vasaikar","year":"2021","unstructured":"Vasaikar SV, Deshmukh AP, den Hollander P, Addanki S, Kuburich NA, Kudaravalli S, Joseph R, Chang JT, Soundararajan R and Mani SA. EMTome: a resource for pan-cancer analysis of epithelial-mesenchymal transition genes and signatures. Br J Cancer 2021; 124: 259-269.","journal-title":"Br J Cancer"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Xie Z, Bailey A, Kuleshov MV, Clarke DJB, Evangelista JE, Jenkins SL, Lachmann A, Wojciechowicz ML, Kropiwnicki E, Jagodnik KM, Jeon M and Ma’ayan A. Gene set knowledge discovery with enrichr. Curr Protoc 2021; 1: e90.","DOI":"10.1002\/cpz1.90"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/MPA.0b013e3181c15963","article-title":"Phenotype and genotype of pancreatic cancer cell lines","volume":"39","author":"EL","year":"2010","unstructured":"Deer EL, González-Hernández J, Coursen JD, Shea JE, Ngatia J, Scaife CL, Firpo MA and Mulvihill SJ. Phenotype and genotype of pancreatic cancer cell lines. Pancreas 2010; 39: 425-435.","journal-title":"Pancreas"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Campbell S, Mesaros C, Izzo L, Affronti H, Noji M, Schaffer BE, Tsang T, Sun K, Trefely S, Kruijning S, Blenis J, Blair IA and Wellen KE. Glutamine deprivation triggers NAGK-dependent hexosamine salvage. Elife 2021; 10: e62644.","DOI":"10.7554\/eLife.62644"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Kim PK, Halbrook CJ, Kerk SA, Radyk M, Wisner S, Kremer DM, Sajjakulnukit P, Andren A, Hou SW, Trivedi A, Thurston G, Anand A, Yan L, Salamanca-Cardona L, Welling SD, Zhang L, Pratt MR, Keshari KR, Ying H and Lyssiotis CA. Hyaluronic acid fuels pancreatic cancer cell growth. Elife 2021; 10: e62645.","DOI":"10.7554\/eLife.62645"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Zhang W, Hou T, Niu C, Song L and Zhang Y. B3GNT3 expression is a novel marker correlated with pelvic lymph node metastasis and poor clinical outcome in early-stage cervical cancer. PLoS One 2015; 10: e0144360.","DOI":"10.1371\/journal.pone.0144360"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3892\/ol.2020.12420","article-title":"B3GNT3: a prognostic biomarker associated with immune cell infiltration in pancreatic adenocarcinoma","volume":"21","author":"Kong","year":"2021","unstructured":"Kong K, Zhao Y, Xia L, Jiang H, Xu M and Zheng J. B3GNT3: a prognostic biomarker associated with immune cell infiltration in pancreatic adenocarcinoma. Oncol Lett 2021; 21: 159.","journal-title":"Oncol Lett"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"103658","DOI":"10.1016\/j.jri.2022.103658","article-title":"Upregulation of B3GNT3 is associated with immune infiltration and activation of NF-kappaB pathway in gynecologic cancers","volume":"152","author":"Xu","year":"2022","unstructured":"Xu J, Guo Z, Yuan S, Li H and Luo S. Upregulation of B3GNT3 is associated with immune infiltration and activation of NF-kappaB pathway in gynecologic cancers. J Reprod Immunol 2022; 152: 103658.","journal-title":"J Reprod Immunol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1136\/jclinpath-2017-204860","article-title":"B3GNT3 overexpression is associated with unfavourable survival in non-small cell lung cancer","volume":"71","author":"Gao","year":"2018","unstructured":"Gao L, Zhang H, Zhang B, Zhu J, Chen C and Liu W. B3GNT3 overexpression is associated with unfavourable survival in non-small cell lung cancer. J Clin Pathol 2018; 71: 642-647.","journal-title":"J Clin Pathol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.18632\/aging.202255","article-title":"B3GNT3 overexpression promotes tumor progression and inhibits infiltration of CD8+ T cells in pancreatic cancer","volume":"13","author":"Zhuang","year":"2020","unstructured":"Zhuang H, Zhou Z, Zhang Z, Chen X, Ma Z, Huang S, Gong Y, Zhang C and Hou B. B3GNT3 overexpression promotes tumor progression and inhibits infiltration of CD8+ T cells in pancreatic cancer. Aging (Albany NY) 2020; 13: 2310-2329.","journal-title":"Aging (Albany NY)"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"18404","DOI":"10.18632\/aging.203290","article-title":"Expression mode and prognostic value of FXYD family members in colon cancer","volume":"13","author":"Jin","year":"2021","unstructured":"Jin M, Zhang H, Yang J, Zheng Z and Liu K. Expression mode and prognostic value of FXYD family members in colon cancer. Aging (Albany NY) 2021; 13: 18404-18422.","journal-title":"Aging (Albany NY)"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Peng X, Gao J, Cai C and Zhang Y. LncRNA LINC01503 aggravates the progression of cervical cancer through sponging miR-342-3p to mediate FXYD3 expression. Biosci Rep 2020; 40: BSR20193371.","DOI":"10.1042\/BSR20193371"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s13273-021-00207-9","article-title":"FXYD3 promotes the proliferation, migration, and invasion of pancreatic cancer cells by regulating the cGMP-PKG signaling pathway","volume":"18","author":"Peng","year":"2022","unstructured":"Peng Y, Zeng X, Lian M and Wang Y. FXYD3 promotes the proliferation, migration, and invasion of pancreatic cancer cells by regulating the cGMP-PKG signaling pathway. Mol Cell Toxicol 2022; 18: 371-381.","journal-title":"Mol Cell Toxicol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/ijc.21257","article-title":"FXYD3 is overexpressed in pancreatic ductal adenocarcinoma and influences pancreatic cancer cell growth","volume":"118","author":"Kayed","year":"2006","unstructured":"Kayed H, Kleeff J, Kolb A, Ketterer K, Keleg S, Felix K, Giese T, Penzel R, Zentgraf H, Buchler MW, Korc M and Friess H. FXYD3 is overexpressed in pancreatic ductal adenocarcinoma and influences pancreatic cancer cell growth. Int J Cancer 2006; 118: 43-54.","journal-title":"Int J Cancer"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1007\/s00018-003-3036-5","article-title":"Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer","volume":"60","author":"Friess","year":"2003","unstructured":"Friess H, Ding J, Kleeff J, Fenkell L, Rosinski JA, Guweidhi A, Reidhaar-Olson JF, Korc M, Hammer J and Buchler MW. Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer. Cell Mol Life Sci 2003; 60: 1180-1199.","journal-title":"Cell Mol Life Sci"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.7150\/thno.71364","article-title":"The role of Jagged1 as a dynamic switch of cancer cell plasticity in PDAC assembloids","volume":"12","author":"Choi","year":"2022","unstructured":"Choi JI, Rim JH, Jang SI, Park JS, Park H, Cho JH and Lim JB. The role of Jagged1 as a dynamic switch of cancer cell plasticity in PDAC assembloids. Theranostics 2022; 12: 4431-4445.","journal-title":"Theranostics"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/BF02796382","article-title":"Human pancreatic adenocarcinoma: In vitro and In vivo morphology of a new tumor line established from ascites","volume":"18","author":"Chen","year":"1982","unstructured":"Chen WH, Horoszewicz JS, Leong SS, Shimano T, Penetrante R, Sanders WH, Berjian R, Douglass HO, Martin EW and Chu TM. Human pancreatic adenocarcinoma: In vitro and In vivo morphology of a new tumor line established from ascites. In Vitro 1982; 18: 24-34.","journal-title":"In Vitro"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1007\/s11596-011-0673-z","article-title":"Re-expression of cell adhesion molecule inhibits growth and induces apoptosis of human pancreatic cancer cell line PANC-1","volume":"31","author":"Liu","year":"2011","unstructured":"Liu Z, Zhu L, Qin H, Li D, Xie Z, Ke X and Zhao Q. Re-expression of cell adhesion molecule inhibits growth and induces apoptosis of human pancreatic cancer cell line PANC-1. J Huazhong Univ Sci Technolog Med Sci 2011; 31: 762-767.","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"183503","DOI":"10.1016\/j.bbamem.2020.183503","article-title":"Role of tight junctions in the epithelial-to-mesenchymal transition of cancer cells","volume":"1863","author":"Kyuno","year":"2021","unstructured":"Kyuno D, Takasawa A, Kikuchi S, Takemasa I, Osanai M and Kojima T. Role of tight junctions in the epithelial-to-mesenchymal transition of cancer cells. Biochim Biophys Acta Biomembr 2021; 1863: 183503.","journal-title":"Biochim Biophys Acta Biomembr"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcr\/14\/9\/ajcr0157139.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:56:16Z","timestamp":1766022976000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/14\/9\/ajcr0157139.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":31,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.62347\/lude7524","relation":{},"ISSN":["2156-6976"],"issn-type":[{"value":"2156-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}